Detalhe da pesquisa
1.
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.
Biochem J
; 479(3): 401-424, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35147166
2.
Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice.
Clin Sci (Lond)
; 136(22): 1661-1681, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36331065
3.
MAP4K4 expression in cardiomyocytes: multiple isoforms, multiple phosphorylations and interactions with striatins.
Biochem J
; 478(11): 2121-2143, 2021 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34032269
4.
The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension.
Clin Sci (Lond)
; 135(14): 1631-1647, 2021 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296750
5.
TNF-α-mediated bronchial barrier disruption and regulation by src-family kinase activation.
J Allergy Clin Immunol
; 132(3): 665-675.e8, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23632299
6.
Cardiac protein kinases: the cardiomyocyte kinome and differential kinase expression in human failing hearts.
Cardiovasc Res
; 108(1): 87-98, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26260799